Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07193641
What this trial is testing

A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 25
Testing effectiveness (Phase 2)Study completedNCT00855894
What this trial is testing

The Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Genentech, Inc. 41
Early research (Phase 1)Ended earlyNCT01886573
What this trial is testing

Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT03102242
What this trial is testing

Atezolizumab Immunotherapy in Patients With Advanced NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Alliance Foundation Trials, LLC. 64
Testing effectiveness (Phase 2)Study completedNCT01935336
What this trial is testing

Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers

Who this might be right for
Adenocarcinoma of the LungExtensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung Cancer+5 more
University of Colorado, Denver 171
Large-scale testing (Phase 3)Study completedNCT00475098
What this trial is testing

Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT)

Who this might be right for
Lung CancerNon Small Cell Lung Cancer
Assistance Publique - Hôpitaux de Paris 553
Testing effectiveness (Phase 2)Study completedNCT00064064
What this trial is testing

3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vion Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT06630611
What this trial is testing

Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)

Who this might be right for
MelanomaNon Small Cell Lung CancerCervical Cancer
Vall d'Hebron Institute of Oncology 40
Testing effectiveness (Phase 2)Study completedNCT00245063
What this trial is testing

AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung Cancer
National Cancer Institute (NCI) 25
Early research (Phase 1)Study completedNCT03801902
What this trial is testing

Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial

Who this might be right for
Locally Advanced Lung Non-Small Cell CarcinomaLocally Recurrent Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8+2 more
National Cancer Institute (NCI) 26
Not applicableUnknownNCT02950337
What this trial is testing

Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Loyola University 41
Testing effectiveness (Phase 2)Study completedNCT00200395
What this trial is testing

OSI-774 (Erlotinib, Tarceva) in Elderly Patients

Who this might be right for
Non-Small Cell Lung Cancer
Montefiore Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT03412877
What this trial is testing

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

Who this might be right for
Endocrine TumorsNon-Small Cell Lung CancerOvarian Cancer+4 more
National Cancer Institute (NCI) 285
Testing effectiveness (Phase 2)Looking for participantsNCT05295212
What this trial is testing

Atezolizumab Combined With Platinum-based Chemotherapy as Neoadjuvant Therapy for Patients With Resectable Stage II-IIIB

Who this might be right for
Non Small Cell Lung Cancer
Hunan Province Tumor Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT06311981
What this trial is testing

Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients

Who this might be right for
Non-small Cell Lung CancerOlder PeopleCarbon Ion Radiotherapy+1 more
Jian Chen 29
Testing effectiveness (Phase 2)Study completedNCT00729612
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Greg Otterson 63
Early research (Phase 1)Study completedNCT00866528
What this trial is testing

Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 30
Large-scale testing (Phase 3)Ended earlyNCT00863512
What this trial is testing

Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 34
Testing effectiveness (Phase 2)Looking for participantsNCT06512051
What this trial is testing

A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Advanced or Metastatic Non-small Cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 248
Testing effectiveness (Phase 2)UnknownNCT00874328
What this trial is testing

TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Advanced Non-Small Cell Lung Cancer
National Cancer Center, Korea 74
Next Page